Immunitas Bio Private Limited
For Vaccines
ImmunitasBio specializes in design and development of cell-based assays to assess and analyze the immunological functions of vaccines, For e.g., Inactivated, Live-attenuated, Viral-vector, mRNA based, Toxoid vaccines etc.
For Immuno-Oncology
Immuno-oncological approaches are opening new avenues in curative cancer treatment. ImmunitasBio provides a platform for such therapies that require specific and sensitive bioanalytical methods and customized oncological assays.
For Custom Assay Development
ImmunitasBio specialize in designing and executing the development of novel immunoassays for drugs and biomarkers. This includes identifying the best sources for proprietary reagents and consumables required for bioanalytical assay development, subcontracting parts of the assay development to third parties, and testing at all intermediate stages.